Digistain
YC S21London, GB · Founded 2019 · 40 employees · 1 known investors
Digistain develops imaging technology to grade breast cancer biopsies and assess cancer recurrence risk faster and more cost-effectively than traditional methods. The company serves breast oncologists and pathologists in clinical and diagnostic settings.
Founders & leadership· Y Combinator alumni (S21)
Investors · 1
In the news
- Sofia Angels Ventures buys into UK-based cancer treatment start-up Digistain | Bulgaria Deals News | SeeNewsseenews.com · 2022
- Sofia Angels Ventures Helps UK Medtech Startup Digistain Raise $1M to Fight Breast Cancertherecursive.com · 2022
- DigiStain gets Y Combinator funding - Digistain - Transformational breast cancer biomarker analyticsdigistain.co.uk · 2021
- Digistain raised $1 million seed from Sofia Angels Ventures and Y Combinator | Nordic 9nordic9.com